Bridgefront Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Buy
+76,917
New +$1.88M 0.46% 50
2023
Q2
Sell
-26,948
Closed -$253K 520
2023
Q1
$253K Buy
+26,948
New +$318K 0.15% 259
2022
Q4
Sell
-24,641
Closed -$306K 399
2022
Q3
$306K Sell
24,641
-550
-2% -$9.61K 0.31% 128
2022
Q2
$494K Buy
+25,191
New +$596K 0.55% 33
2021
Q3
Sell
-8,682
Closed -$301K 439
2021
Q2
$301K Buy
+8,682
New +$286K 0.11% 338

Other funds holding ELAN

Bridgefront Capital's ELAN Position: Q1 2026 in Review

Bridgefront Capital opened a new position in Elanco Animal Health (ELAN) in Q1 2026: 76,917 shares worth $1.84M. The stake represents 0.46% of the portfolio and ranks #50 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in ELAN as recently as Q1 2023.

Bridgefront Capital first reported a position in ELAN in Q2 2021 and has held it in 5 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Bridgefront Capital held 76,917 shares of Elanco Animal Health worth $1.84M as of Q1 2026.
  • Elanco Animal Health was a new Bridgefront Capital position in Q1 2026.
  • Elanco Animal Health made up 0.46% of Bridgefront Capital's portfolio in Q1 2026, its #50 holding.
  • Bridgefront Capital first reported a position in Elanco Animal Health in Q2 2021 and has held it in 5 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.